236 related articles for article (PubMed ID: 30951732)
1. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
2. Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors.
Eveno T; Dirr L; El-Deeb IM; Guillon P; von Itzstein M
Viruses; 2019 May; 11(5):. PubMed ID: 31060278
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.
Alymova IV; Taylor G; Takimoto T; Lin TH; Chand P; Babu YS; Li C; Xiong X; Portner A
Antimicrob Agents Chemother; 2004 May; 48(5):1495-502. PubMed ID: 15105096
[TBL] [Abstract][Full Text] [Related]
4. Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin-Neuraminidase Using Unsaturated 3- N-Substituted Sialic Acids as Probes.
Pascolutti M; Dirr L; Guillon P; Van Den Bergh A; Ve T; Thomson RJ; von Itzstein M
ACS Chem Biol; 2018 Jun; 13(6):1544-1550. PubMed ID: 29693380
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
7. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus.
Ryan C; Zaitsev V; Tindal DJ; Dyason JC; Thomson RJ; Alymova I; Portner A; von Itzstein M; Taylor G
Glycoconj J; 2006 Feb; 23(1-2):135-41. PubMed ID: 16575531
[TBL] [Abstract][Full Text] [Related]
9. Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.
Marcink TC; Yariv E; Rybkina K; Más V; Bovier FT; des Georges A; Greninger AL; Alabi CA; Porotto M; Ben-Tal N; Moscona A
mBio; 2020 Feb; 11(1):. PubMed ID: 32047132
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
[TBL] [Abstract][Full Text] [Related]
11. Epicatechin analogues may hinder human parainfluenza virus infection by inhibition of hemagglutinin neuraminidase protein and prevention of cellular entry.
Bhasin S; Nadar M; Hasija Y
J Mol Model; 2022 Sep; 28(10):319. PubMed ID: 36109366
[TBL] [Abstract][Full Text] [Related]
12. Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors.
Guillon P; Dirr L; El-Deeb IM; Winger M; Bailly B; Haselhorst T; Dyason JC; von Itzstein M
Nat Commun; 2014 Oct; 5():5268. PubMed ID: 25327774
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties.
Gorman WL; Pridgen C; Portner A
Virology; 1991 Jul; 183(1):83-90. PubMed ID: 1647078
[TBL] [Abstract][Full Text] [Related]
14. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by α-acylaminoamido groups at the C-4 position using isocyanide-based four-component coupling and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Hayakawa T; Takahashi T; Suzuki T; Sato M; Ikeda K
Chem Pharm Bull (Tokyo); 2013; 61(1):69-74. PubMed ID: 23302587
[TBL] [Abstract][Full Text] [Related]
15. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
[TBL] [Abstract][Full Text] [Related]
16. Origin of the inhibitory activity of 4-O-substituted sialic derivatives of human parainfluenza virus.
Itoh Y; Sando A; Ikeda K; Suzuki T; Tokiwa H
Glycoconj J; 2012 May; 29(4):231-7. PubMed ID: 22581169
[TBL] [Abstract][Full Text] [Related]
17. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).
Murrell M; Porotto M; Weber T; Greengard O; Moscona A
J Virol; 2003 Jan; 77(1):309-17. PubMed ID: 12477836
[TBL] [Abstract][Full Text] [Related]
18. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein.
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z
Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646
[TBL] [Abstract][Full Text] [Related]
19. Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation.
Iketani S; Shean RC; Ferren M; Makhsous N; Aquino DB; des Georges A; Rima B; Mathieu C; Porotto M; Moscona A; Greninger AL
mBio; 2018 Jul; 9(4):. PubMed ID: 29970463
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Ikeda K; Hayakawa T; Takahashi T; Suzuki T; Sato M
Bioorg Med Chem; 2011 Apr; 19(7):2418-27. PubMed ID: 21382718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
